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Abstract
Purpose:  Selective  transarterial  embolization  (TAE)  of  the  internal  iliac  artery  is  a  well-known
alternative  technique  to  control  intractable  bladder  hemorrhage  (IBH).  We  explored  the  short-
and long-term  effectiveness  of,  and  clinical  outcomes  after,  TAE  in  patients  with  IBH.
Materials  and  methods:  In  this  retrospective  study,  we  reviewed  the  hospital  records  of  18
IBH patients  non-responsive  to  conservative  medications  who  underwent  TAE  between  January
2003 and  May  2014.  The  early-  and  long-term  effectiveness  of  TAE  was  investigated  in  the
context of  hematuria  control,  complications,  mortality,  requirement  for  blood  transfusions,
and hematocrit  level.
Results:  Sixteen  of  the  18  patients  underwent  endovascular  treatment;  the  technical  suc-
cess rate  was  88%.  TAE  allowed  complete  remission  in  16  patients  (100%  clinical  success).  On
follow-up,  mean  hematocrit  (P  =  0.003)  and  hemoglobin  (P  =  0.005)  levels  signiﬁcantly  improved.
Thirteen of  the  16  patients  (81%)  required  no  further  emergency  admission  after  TAE  during  a
mean follow-up  period  of  18.1  months  (range,  3—105  months).
Conclusion:  TAE  is  a  feasible,  effective,  and  safe  technique  in  both  the  short-  and  long-term
for the  treatment  of  IBH.
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Intractable  bladder  hemorrhage  (IBH)  is  a  serious  compli-
ation  in  patients  with  carcinoma  and  an  important
ause  of  morbidity  and  mortality  [1—4].  Various  conditions
ncluding  urogenital  pelvic  malignancies,  radiation  cysti-
is,  chemotherapy-induced  hemorrhagic  cystitis,  and  urinary
ract  infections,  can  trigger  IBH  [5].  Medical  treatment  of
cute  hemorrhage  includes  bladder  irrigation  with  saline,
lum,  or  formalin,  or  bladder  hydrodistension.  When  a  con-
ervative  approach  fails,  ligation  of  the  internal  iliac  artery
r  cystectomy  may  be  required  [5].  Elderly  patients  living
nder  poor  conditions  constitute  most  cases,  leading  to  high
orbidity  associated  with  surgical  procedures.  Given  the
elatively  low  effectiveness  of  medical  approaches  to  treat
BH  [4,6,7],  minimally  invasive  procedures  are  preferable.
elective  transarterial  embolization  (TAE)  of  the  inter-
al  iliac  artery  is  a  well-described  alternative  technique
sed  to  control  severe  hematuria,  and  has  been  success-
ully  applied  over  many  years  to  treat  bladder  hemorrhage
ssociated  with  terminal  pelvic  malignancy  [1,8].  Although
any  reports  on  TAE  to  treat  IBH  have  appeared,  most  are
ase  reports  or  small  case  series,  and  long-term  outcomes
fter  TAE  remain  unclear  [9—13].  In  the  present  study,  we
xplored  the  short-  and  long-term  effectiveness,  and  clin-
cal  outcomes,  of  patients  who  underwent  TAE  to  prevent
BH.
aterials and methods
his  study  was  approved  by  our  institutional  Ethics  Commit-
ee.  The  medical  records  of  18  IBH  patients  who  underwent
AE  of  the  internal  iliac  artery/arteries  between  January
003  and  May  2014  were  retrospectively  analyzed.  We
etrieved  data  on  gender,  age,  manifestations  of  the  disorder
nd  other  associated  conditions,  procedure  used,  hema-
uria  control,  angiographic  ﬁndings  before  and  after  TAE,
esponse  to  TAE,  complications,  follow-up  duration,  and
hort-  and  long-term  effectiveness.  A  total  of  18  patients
14  males,  4  females)  were  included.  The  mean  age  of  all
articipants  was  67  years  (range,  18—92  years).  The  cause  of
leeding  was  bladder  cancer  in  six  patients,  prostate  can-
er  in  six,  radiation  cystitis  in  two,  cervical  cancer  with
ladder  invasion  in  two,  endometrial  cancer  with  bladder
nvasion  in  one,  and  hemorrhagic  cystitis  in  one  (Table  1).
n  all  patients,  conservative  modalities  including  continu-
us  irrigation  of  the  bladder  using  a  three-way  catheter
nd  endoscopic  interventions,  were  tried  for  a  mean  of
Table  1  Demographical  data  on  factors  lead  to
hematuria.
Cause  of  hematuria  Number  of  patients
Prostate  cancer 6  (33%)
Bladder  cancer  6  (33%)
Cervical  cancer 2  (11%)
Endometrial  cancer 1  (6%)
Radiation  cystitis  2  (11%)
Hemorrhagic  cystitis  1  (6%)
Total  18
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wo  days  (range,  1—3  days),  but  failed.  Surgery  was  not
n  option  for  15  patients  (83%)  with  signiﬁcant  comorbidi-
ies.  Only  three  patients  had  no  comorbidities  (17%).  Of
ll  patients,  eight  had  coronary  artery  disease  and  dia-
etes  mellitus,  three  chronic  obstructive  pulmonary  disease,
hree  coronary  artery  disease  and  hypertension,  and  one
hronic  kidney  disease.  Eleven  patients  had  been  using
cetylsalicylic  acid  (ASA)  prophylactically,  but  this  medica-
ion  had  been  withdrawn  to  prevent  possible  hemorrhagic
nsult.  Blood  specimens  were  collected  from  all  patients  to
xclude  any  coagulopathic  disorder,  and  prophylactic  antibi-
tics  were  given  prior  to  TAE.
All  embolizations  were  performed  by  two  specialists
xperienced  in  interventional  radiology.  After  obtaining
ritten  informed  consent,  intervention  was  initiated  by
ntering  the  femoral  artery.  Angiography  was  performed
sing  a  5F  pig-tail  catheter  to  identify  any  abnormal  vas-
ularization  of  the  pelvic  region.  Cobra  or  Simmons  type-2
atheters  were  selectively  placed  in  the  internal  iliac  arter-
es.  Vascularization  status  in  the  context  of  hematuria
as  evaluated  and  prostatic/vesical  branches  superselec-
ively  cathetherised  using  2.9  Fr  coaxial  microcatheters.
olyvinyl  alcohol  (PVA)  particles  300—500  m  in  diame-
er  were  employed  for  distal  embolization.  Next,  particles
00—700  m  in  diameter  were  injected  to  embolize  more
roximal  abnormal  vessels.
When  vesical  or  prostatic  arteries  could  not  be  selectively
atheterised,  we  performed  particulate  embolization  com-
ined  with  coil  blockade.  We  ﬁrst  occluded  distal  branches
t  their  ostia  with  preservation  of  the  ﬂow  of  normal  vesical
r  prostatic  branches;  this  steered  particles  into  abnormal
ranches  to  prevent  distal  particulate  embolization  of  nor-
al  branches  and  thus  reduce  clinical  complications.  Coil
lockade  was  performed  with  the  aid  of  0.018-inch  ﬁbre
r  soft  platinum  microcoils  of  various  lengths  and  diam-
ters.  When  it  was  impossible  to  selectively  catetherize
he  principal  distal  branches  of  the  anterior  division  of
he  internal  iliac  artery,  the  catheter  tip  was  left  in  the
nterior  division  of  that  artery  and  embolization  performed
t  that  point  using  0.035-inch  steel  coils  of  appropri-
te  diameter  or  mechanically  disrupted  using  absorbable,
elatin  sponge  powder,  regardless  of  whether  bleeding  was
vident  angiographically.  At  the  end  of  each  interven-
ion,  the  technical  status  of  the  procedure  was  reviewed
ngiographically.  Identical  procedures  were  performed  on
he  opposite  side  via  an  ipsi-  or  contra-lateral  puncture
Figs.  1  and  2).  Although  we  planned  bilateral  superselective
VA  embolization,  only  11  of  the  16  patients  could  undergo
his  procedure.  Selective  proximal  coil  occlusion  of  the  ante-
ior  divisions  of  internal  iliac  arteries  was  performed  in  two
atients,  and  both  arteries  were  occluded  in  one  patient.
oil  blockade  was  performed  in  one  patient  (Table  2).
atients  were  followed-up  in  terms  of  the  short-  and
ong-term  effectiveness  of  the  procedures  used  to  control
ematuria,  complications,  mortality,  need  for  blood  trans-
usions,  and  hematocrit  level.  The  post-treatment  follow-up
eriod  was  3—105  months  (mean,  18.1  months).  Statistical
nalysis  was  conducted  using  Sofa  Statistics  software  ver-
ion  1.4.3  (http://www.sofastatistics.com).  Between-group
omparisons  were  made  using  Student’s  t-test  and  a  P
alue  less  than  0.05  was  considered  to  reﬂect  statistical
igniﬁcance.
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Figure 1. Left internal iliac arteriograms: a: increased vascularity is evident prior to operation; b: selective catheterization of the vesical
artery during TAE with c, and after TAE with PVA.
Figure 2. Left internal iliac arteriograms: a: hypervascularization is obvious prior to TAE; b: selective intraoperative catheterization with
c, and after TAE performed using PVA and coils.
Table  2  Embolization  methods  and  embolic  agents  used.
Techniques  Embolic  agent  Bilateral  embolization,  %  Number  of  patientsb
Superselective  PVAa 100  11
Selective  Coils  100  2
Superselective  and  selective  PVA  +  Coils  100  2
Coil  blockade  Coils  +  PVA  100  1
a PVA indicates polyvinyl alcohol.
b No embolic agent was used in two patients because of technical failure.
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We  included  a  total  of  18  IBH  patients  (14  males  and  4
females;  mean  age  67  years,  range  18—92  years)  who  under-
went  TAE.  Prior  to  intervention,  an  average  of  three  units  of
blood  was  given  to  all  patients.  Endovascular  treatment  was
feasible  in  16  of  18  patients;  the  technical  success  rate  was
88%.  In  the  remaining  two  patients  the  internal  iliac  arteries
had  been  occluded  by  prior  radiotherapy  and  atheroscle-
rotic  disease.  One  of  these  patients  died  of  complications
of  an  associated  condition.  The  other  underwent  radical
surgery  and  died  of  comorbid  causes  although  bleeding
had  ceased.  TAE  completely  stopped  hemorrhage  in  all  16
patients  within  24,  48,  and  72  h  in  10,  4,  and  2  patients,
respectively,  translating  to  a  100%  clinical  success  rate.  On
follow-up,  signiﬁcant  improvements  in  mean  hematocrit  and
hemoglobin  levels  were  evident;  these  increased  from  26.95
to  30.11%  (P  =  0.003)  and  from  8.95  to  10.25  g/dL  (P  =  0.005)
prior  to  discharge,  respectively  (Fig.  3).  No  serious  complica-
tion  was  associated  with  TAE;  minor  complications  included
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[luteal  pain,  nausea,  vomiting,  and  fever  in  ﬁve  patients.
he  complications  persisted  for  approximately  three  days
nd  disappeared  after  palliative  treatment.  The  glomeru-
ar  ﬁltration  rate  did  not  fall  after  embolization.  The  mean
ospitalisation  time  after  TAE  was  four  days.  During  a  mean
ollow-up  period  of  18.1  months  (range  3—105  months),  13
f  the  16  patients  exhibited  good  bleeding  control  and  did
ot  require  further  emergency  admission  to  treat  hema-
uria. I˙n  the  remaining  three  patients,  hematuria  recurred
fter  1  month  and  was  controlled  medically,  without  further
mbolization.  Of  all  participants,  seven  died  from  underly-
ng  conditions  during  follow-up  (Table  3).
iscussionBH  can  be  lethal  in  patients  with  bladder  cancer  or  cys-
itis  and  is  associated  with  high  morbidity  and  mortality
1—4]. Various  therapeutic  approaches  have  been  described
5]. Bladder  irrigation,  Helmstein  balloon  compression,  and
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Figure 3. Changes in hematocrit and hemoglobin levels during follow-up.
Table  3  Overall  results  of  the  current  study.
Technical
success  (%)
Short-term
clinical
success  (%)
Long-term
clinical
success  (%)
Early
re-bleeding
rate  (before
1  month)  (%)
Late
re-bleeding
rate  (after
1  month)  (%)
Major
complications
(%)
Minor
complications
(%)
1  month
mortality
rate  (%)
19
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w88%  (16/18)  100%  (16/16)  81%  (13/16)  0%  (0/16)  
ystoscopic  clot  evacuation  are  among  the  most  conser-
ative  methods  [14].  However,  no  speciﬁc  treatment  for
BH  has  been  deﬁned  to  date  although  some  patients  may
ot  respond  to  medical  care  [7,15].  Surgical  interventions
ncluding  internal  iliac  artery  ligation  or  cystectomy  consti-
ute  last  resorts  for  control  of  IBH.  These  procedures  are
ssociated  with  high  mortality  and  morbidity  because  most
atients  with  refractory  bleeding  are  elderly  and  gener-
lly  live  under  poor  conditions  [9,16].  TAE  is  a  minimally
nvasive  procedure  with  a  lower  morbidity  rate  and  affords
dvantages  over  surgical  interventions.  Thus,  TAE  can  be
ffective  to  treat  IBH  [7,9,16].  Internal  iliac  embolization
as  ﬁrst  introduced  by  Hald  and  Mygind  in  1974  [17]. Since
hat  time,  the  indications  for  transcatheter  TAE  have  grad-
ally  increased  in  number  to  include  the  management  of
raumatic  hemorrhage,  obstetric  or  iatrogenic  insults,  and
eoplasms  of  the  urogenital  region  [3,7,18—20].  In  previous
tudies,  the  clinical  success  rates  of  TAE  were  92.6—100%
1,10—13,21].  Our  initial  success  rate  was  100%,  in  accor-
ance  with  the  literature.  Although  TAE  is  known  to  rapidly
ontrol  IBH,  most  prior  studies  were  small  case  series,  leav-
ng  the  long-term  outcomes  of  patients  undergoing  TAE
o  treat  severe  IBH  unclear.  Prasad  et  al.  [21]  and  Del-
al  et  al.  [22]  reported  technical  success  rates  of  90%  and
00%,  and  clinical  success  rates  of  100%  and  100%,  respec-
ively,  in  accordance  with  our  ﬁndings.  However,  Delgal
t  al.  [22]  reported  that  three  of  four  patients  with  late
leeding  relapses  had  radiation  cystitis.  In  our  study,  two
f  three  patients  with  late  re-bleeding  exhibited  radiation
ystitis  despite  bilateral  embolization,  suggesting  that  such
atients  are  at  particular  risk  of  late  re-bleeding.  Liguori
t  al.  [16]  performed  superselective  embolization  on  44
atients  with  pelvic  malignancies;  hemorrhage  was  per-
anently  controlled  in  19  patients  (43%)  over  a  mean  of
0.5  months  of  follow-up  (range  1—97  months).  A  second
w
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o%  (3/16)  0%  (0/16)  31%  (5/16)  0%  (0/16)
AE  was  required  in  ﬁve  (11%)  patients  and  was  success-
ul  in  two.  In  our  present  study,  all  16  patients  (100%)
xhibited  favourable  hematuria  control  and  13  did  not
equire  emergency  admission  over  a  mean  follow-up  period
f  18.1  months  (range  3—105  months).  Recurrences  in  three
atients  were  controlled  medically.  We  had  a  relatively
onger  follow-up  period  (with  low  recurrence)  compared  to
hat  of  Liguori  et  al.  [16].  Nabi  et  al.  [9]  and  El-Assmy  et  al.
23]  reported  favorable  long-term  outcomes  in  patients  with
BH  secondary  to  pelvic  neoplasms.  However,  the  numbers
f  patients  in  the  cited  studies  were  relatively  low.
The  best  embolic  agent  and  optimal  embolization  tech-
ique  remain  controversial.  Again,  in  most  previous  reports,
atient  numbers  were  small  [12,13,23,24].  Although  vari-
us  embolic  materials  have  been  historically  used,  all  recent
tudies  indicate  that  superselective  embolization  with  PVA
articles  is  optimal;  complication  rates  are  low  and  suc-
ess  rates  high  [1,16,21,22].  Hovewer,  embolization  must
lways  be  bilateral;  contralateral  vascular  bundles  can  trig-
er  recurrent  bleeding  especially  when  malignancies  are
ssociated  with  single-sided  blood  perfusion.
Rare  complications  of  TAE  include  post-embolization  syn-
rome,  gluteal  pain,  bacterial  sepsis,  walking  disorders,
ncommon  necrosis  of  the  bladder,  Brown-Sequard’s  syn-
rome,  and  skin  necrosis  [25,26].  Compared  to  selective
mbolization,  superselective  procedures  are  associated  with
ower  rates  of  recurrent  bleeding  and  minimisation  of  side
ffects  including  gluteal  pain,  claudication,  tissue  necro-
is,  and  the  need  for  morphine  to  relieve  pain  [27].  Liguori
t  al.  [16]  found  that  no  major  complication  related  to  TAE
as  evident  during  follow-up;  post-embolization  syndrome
as  a  minor  complication  in  12  patients  (27%).  Likewise,
e  observed  no  major  complication;  minor  complications
ncluding  fever,  gluteal  pain,  nausea,  and  vomiting  devel-
ped  in  ﬁve  patients  (31%)  and  persisted  for  an  average  of
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three  days  during  long-term  follow-up,  in  contrast  with  the
ﬁndings  of  other  series  [8].  TAE  should  be  performed  distal  to
the  anterior  compartment  of  the  internal  iliac  artery,  using
unresorbable  PVA  particles  to  preserve  gluteal  artery  per-
fusion  and  to  prevent  complications  including  severe  pain  in
the  buttocks  and  upper  thighs.
Our  current  study  also  features  a  relatively  small  number
of  patients,  as  IBH  is  rare.  Also,  the  work  was  retrospective
in  nature  and  detailed  clinical  data  on  patients  prior  to  inter-
vention  were  not  always  available.  Moreover,  neither  patient
number  nor  the  duration  of  follow-up  was  standardized.
Studies  with  more  patients  and  longer  follow-up  periods  are
required.
Conclusion
TAE  is  a  feasible,  effective,  and  safe  treatment  for  IBH  in
both  the  short-  and  long-term.
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